Significant pathways [21/95] pathways contains significant subpathways MAPK signaling pathway (hsa04010)
Chemokine signaling pathway (hsa04062)
Cell cycle (hsa04110)
Oocyte meiosis (hsa04114)
Apoptosis (hsa04210)
Wnt signaling pathway (hsa04310)
Notch signaling pathway (hsa04330)
Axon guidance (hsa04360)
Focal adhesion (hsa04510)
Jak-STAT signaling pathway (hsa04630)
Neurotrophin signaling pathway (hsa04722)
Regulation of actin cytoskeleton (hsa04810)
Insulin signaling pathway (hsa04910)
Melanogenesis (hsa04916)
Type II diabetes mellitus (hsa04930)
Pathways in cancer (hsa05200)
Colorectal cancer (hsa05210)
Endometrial cancer (hsa05213)
Prostate cancer (hsa05215)
Acute myeloid leukemia (hsa05221)
Non-small cell lung cancer (hsa05223)
Drug repurposing [?]
None
Drugbank (The triangular compound term that is associated
with greater than or equal to genes)
Drugbank w/ drug-likeness (The triangular compound term that is associated
with greater than or equal to genes)
PharmGKB (The triangular drug term that is associated
with greater than or equal to genes)
PharmGKB w/ drug-likeness (The triangular drug term that is associated
with greater than or equal to genes)
Diseases (HGMD) (The triangular disease term that is
associated with greater than or equal to genes)
All rights reserved to BIBS laboratory, Seoul National University, Korea. |